 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Medical News Four-in-One HIV Pill Enters Late-Stage Clinical TestingApril 13, 2010 "Gilead Sciences Inc. said Monday it started late stage clinical testing of its four-in-one 'Quad' HIV tablet," the Associated Press reports. The pill includes the drugs elvitegravir, cobicistat, and the two components of Truvada, emtricitabine and tenofovir (4/12). "The Phase III clinical program for the Quad includes two studies ... that will evaluate the Quad regimen versus a standard of care among" HIV-positive adults who have not yet started antiretroviral treatment, according to a Gilead press release (4/12). Back to other news for April 2010
 This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
 |
Email
Comments
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
